Skip to main navigation Skip to search Skip to main content

Primary cutaneous cryptococcosis during infliximab therapy

  • Anca Chiriac
  • , Mihai Mares
  • , Doina Mihaila
  • , Caius Solovan
  • , Cosmin Moldovan*
  • , Simona Stolnicu
  • , Ferry Hagen
  • *Corresponding author for this work

Research output: Contribution to journalLetterAcademicpeer-review

Original languageEnglish
Article numbere12405
JournalDermatologic therapy
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 2017
Externally publishedYes

Keywords

  • Administration, Oral
  • Aged
  • Antifungal Agents/administration & dosage
  • Antirheumatic Agents/adverse effects
  • Arthritis, Rheumatoid/diagnosis
  • Biopsy
  • Cryptococcosis/chemically induced
  • Cryptococcus neoformans/immunology
  • Dermatomycoses/chemically induced
  • Drug Administration Schedule
  • Female
  • Fluconazole/administration & dosage
  • Humans
  • Immunocompromised Host
  • Infliximab/adverse effects
  • Opportunistic Infections/chemically induced
  • Treatment Outcome

Cite this